Depression in small-vessel disease relates to white matter ultrastructural damage, not disability

Neurology

Volumn 83, Issue 16, 2014, Pages 1417-1423

  Brookes, Rebecca L ^a   Herbert, Vanessa ^a   Lawrence, Andrew J ^a   Morris, Robin G ^c   Markus, Hugh S ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DIFFUSION TENSOR IMAGING; DISABILITY; DISEASE ASSOCIATION; FEMALE; FRACTIONAL ANISOTROPY; HUMAN; LACUNAR STROKE; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; QUALITY OF LIFE; STROKE PATIENT; ULTRASTRUCTURE; WHITE MATTER LESION; ANISOTROPY; BIOLOGICAL MODEL; BRAIN; DIFFUSION WEIGHTED IMAGING; MIDDLE AGED; PATHOLOGY; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; TIME; VERY ELDERLY; WHITE MATTER;

AGED; AGED, 80 AND OVER; ANISOTROPY; BRAIN; BRAIN ISCHEMIA; CEREBRAL SMALL VESSEL DISEASES; COGNITION; CROSS-SECTIONAL STUDIES; DEPRESSION; DIFFUSION MAGNETIC RESONANCE IMAGING; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, NEUROLOGICAL; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; STROKE, LACUNAR; TIME FACTORS; WHITE MATTER;

EID: 84925547043     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000882     Document Type: Article

References (33)

1. Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Subcortical ischaemic vascular dementia. Lancet Neurol 2002;1:426-436.
2. O'Brien JT, Erkinjuntti T, Reisberg B, et al. Vascular cognitive impairment. Lancet Neurol 2003;2:89-98.
3. Brookes RL, Willis TA, Patel B, Morris RG, Markus HS. Depressive symptoms as a predictor of quality of life in cerebral small vessel disease, acting independently of disability: a study in both sporadic small vessel disease and CADASIL. Int J Stroke 2013;8:510-517.
4. Desmond DW, Moroney JT, Lynch T, Chan S, Chin SS, Mohr JP. The natural history of CADASIL: a pooled analysis of previously published cases. Stroke 1999;30:1230-1233.
5. Taylor WD, Aizenstein HJ, Alexopoulos GS. The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry 2013;18:963-974.
6. Allan CL, Sexton CE, Kalu UG, et al. Does the Framing-ham Stroke Risk Profile predict white-matter changes in late-life depression? Int Psychogeriatr 2012;24:524-531.
7. Alves GS, Karakaya T, Fusser F, et al. Association of microstructural white matter abnormalities with cognitive dysfunction in geriatric patients with major depression. Psychiatry Res 2012;203:194-200.
8. Sexton CE, Le Masurier M, Allan CL, et al. Magnetic resonance imaging in late-life depression: vascular and glu-cocorticoid cascade hypotheses. Br J Psychiatry 2012;201: 46-51.
9. Tang WK, Chen YK, Lu JY, et al. White matter hyper-intensities in post-stroke depression: a case control study. J Neurol Neurosurg Psychiatry 2010;81:1312-1315.
10. Kim JT, Park MS, Yoon GJ, et al. White matter hyper-intensity as a factor associated with delayed mood disorders in patients with acute ischemic stroke. Eur Neurol 2011; 66:343-349.
11. Mok VC, Wong A, Wong K, et al. Executive dysfunction and left frontal white matter hyperintensities are correlated with neuropsychiatric symptoms in stroke patients with confluent white matter hyperintensities. Dement Geriatr Cogn Disord 2010;30:254-260.
12. Dotson VM, Zonderman AB, Kraut MA, Resnick SM. Temporal relationships between depressive symptoms and white matter hyperintensities in older men and women. Int J Geriatr Psychiatry 2013;28:66-74.
13. Santos M, Gold G, Kovari E, et al. Neuropathological analysis of lacunes and microvascular lesions in late-onset depression. Neuropathol Appl Neurobiol 2010;36:661-672.
14. Rainer MK, Mucke HA, Zehetmayer S, et al. Data from the VITA Study do not support the concept of vascular depression. Am J Geriatr Psychiatry 2006;14:531-537.
15. Grool AM, van der Graaf Y, Vincken KL, Witkamp TD, Mali WP, Geerlings MI. Antidepressant use is related to larger white matter lesion volume in patients with symptomatic atherosclerotic disease: the SMART-MR Study. J Neurol 2013;260:197-206.
16. Teodorczuk A, Firbank MJ, Pantoni L, et al. Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS Study. Psychol Med 2010;40:603-610.
17. Pohjasvaara T, Leppavuori A, Siira I, Vataja R, Kaste M, Erkinjuntti T. Frequency and clinical determinants of poststroke depression. Stroke 1998;29:2311-2317.
18. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337:1521-1526.
19. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982;17:37-49.
20. Lawrence AJ, Patel B, Morris RG, et al. Mechanisms of cognitive impairment in cerebral small vessel disease: multimodal MRI results from the St George's Cognition and Neuroimaging in Stroke (SCANS) Study. PLoS One 2013;8:e61014.
21. Brookes RL, Hannesdottir K, Lawrence R, Morris RG, Markus HS. Brief Memory and Executive Test: evaluation of a new screening test for cognitive impairment due to small vessel disease. Age Ageing 2012;41:212-218.
22. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149:351-356.
23. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
24. Williams LS, Weinberger M, Harris LE, Biller J. Measuring quality of life in a way that is meaningful to stroke patients. Neurology 1999;53:1839-1843.
25. Rankin J. Cerebral vascular accidents in patients over the age of 60: II: prognosis. Scott Med J 1957;2:200-215.
26. Mahoney FI, Barthel DW. Functional evaluation: the Bar-thel Index. Md State Med J 1965;14:61-65.
27. Pantoni L, Basile AM, Pracucci G, et al. Impact of age-related cerebral white matter changes on the transition to disability: the LADIS Study: rationale, design and methodology. Neuroepidemiology 2005;24:51-62.
28. Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal 2001;5:143-156.
29. Neeman M, Freyer JP, Sillerud LO. A simple method for obtaining cross-term-free images for diffusion anisotropy studies in NMR microimaging. Magn Reson Med 1991; 21:138-143.
30. Smith SM, Jenkinson M, Johansen-Berg H, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006;31:1487-1505.
31. O'Brien JT, Firbank MJ, Krishnan MS, et al. White matter hyperintensities rather than lacunar infarcts are associated with depressive symptoms in older people: the LADIS Study. Am J Geriatr Psychiatry 2006;14:834-841.
32. Alexopoulos GS. The vascular depression hypothesis: 10 years later. Biol Psychiatry 2006;60:1304-1305.
33. Alexopoulos GS, Bruce ML, Silbersweig D, Kalayam B, Stern E. Vascular depression: a new view of late-onset depression. Dialogues Clin Neurosci 1999;1:68-80.